rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
1999-2-9
|
pubmed:abstractText |
We carried out a randomized placebo-controlled trial in very low birth weight neonates (VLBWNs), comparing the incidence of nosocomial infections after the prophylactic use of recombinant human granulocyte-macrophage colony-stimulating factor (rhu GM-CSF) versus placebo in VLBWNs.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
AIM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0022-3476
|
pubmed:author |
pubmed-author:AgostiJJ,
pubmed-author:CairoM SMS,
pubmed-author:EllisRR,
pubmed-author:FanaroffAA,
pubmed-author:GivnerLL,
pubmed-author:LaverJ JJJ,
pubmed-author:NesinMM,
pubmed-author:PuppalaBB,
pubmed-author:RADUE MEM,
pubmed-author:WheelerJ GJG,
pubmed-author:deLemosRR,
pubmed-author:van de VenCC
|
pubmed:issnType |
Print
|
pubmed:volume |
134
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
64-70
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:9880451-Cross Infection,
pubmed-meshheading:9880451-Double-Blind Method,
pubmed-meshheading:9880451-Eosinophils,
pubmed-meshheading:9880451-Female,
pubmed-meshheading:9880451-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:9880451-Humans,
pubmed-meshheading:9880451-Infant, Newborn,
pubmed-meshheading:9880451-Infant, Very Low Birth Weight,
pubmed-meshheading:9880451-Injections, Intravenous,
pubmed-meshheading:9880451-Leukocyte Count,
pubmed-meshheading:9880451-Male,
pubmed-meshheading:9880451-Recombinant Proteins,
pubmed-meshheading:9880451-United States
|
pubmed:year |
1999
|
pubmed:articleTitle |
A randomized, double-blind, placebo-controlled trial of prophylactic recombinant human granulocyte-macrophage colony-stimulating factor to reduce nosocomial infections in very low birth weight neonates.
|
pubmed:affiliation |
Georgetown University and Lombardi Cancer Center, Washington, DC 20007, USA.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|